Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight

Addiction Medicine

  • Article

    Emerging Threat: Illicit Drugs Adulterated with Xylazine

    September 1, 2023

    Xylazine is a semi-synthetic, non-opioid, sedative paralytic used in veterinary medicine as a tranquilizer. It’s an alpha agonist, similar in chemical structure to clonidine and dexmetomidine.1 It...

  • Article

    Using Naltrexone for AUD is Safe in Patients With and Without Liver Disease

    June 1, 2023

    Dr. Hoang Clinical question: Is naltrexone hepatically safe for the treatment of alcohol use disorder (AUD) in patients with and without liver disease? Background: Treatment of underlying AUD...

  • Article

    Implementation of a Comprehensive Hospitalist-led Initiative to Improve Care for Patients with OUD

    May 1, 2023

    Clinical question: Can a multidisciplinary, hospitalist-led program improve care for hospitalized patients with opioid use disorder (OUD)? Background: Despite rising opioid-related hospitalizations...

  • Article

    Early Treatment with Thiamine and Mortality Among Patients with AUD Who are Hospitalized for Pneumonia

    May 1, 2023

    Dr. Chace Clinical question: Does early thiamine administration improve mortality outcomes for patients with alcohol use disorder who are hospitalized for pneumonia? Background: Wernicke’s...

  • Article

    Low-dose Buprenorphine Initiation is a Safe and Effective Alternative to Standard-dose Buprenorphine in Hospitalized Patients with OUD

    May 1, 2023

    Dr. Vuong Clinical question: Is low-dose buprenorphine initiation in hospitalized patients safe and effective for the management of opioid use disorder (OUD)? Background: OUD is a chronic...

  • Article

    Duration of Abstinence from Alcohol Prior to Liver Transplantation Does Not Lead to Increased Survival in Patients with Alcohol-related Liver Disease

    March 1, 2023

    Clinical question: How does the duration of abstinence from alcohol affect patient survival, allograft survival, and relapse-free survival in patients undergoing liver transplantation? Background:...

  • Article

    Breaking News: X-waiver Eliminated

    January 25, 2023

    On January 12, 2023, the U.S. Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-waiver for...

  • Article

    How Do You Address Ongoing In-hospital Substance Use Among Adults with SUD?

    October 3, 2022

    Case A 28-year-old man with a past medical history notable for severe opioid use disorder and aortic valve endocarditis requiring valve replacement was admitted with recurrent bacteremia, prosthetic...

  • Article

    Recognizing and Treating Substance Use in the Inpatient Setting

    July 1, 2022

    Presenters: Erin McKnight, MD, MPH, Nationwide Children’s Hospital, Columbus, Ohio, Hilary Lin, MD, Children’s Health Orange County, Orange County, Calif., Stephanie Kwon, DO, Medical University...

  • Article

    New HHS Guidance for Increasing Number of Buprenorphine Clinicians Who Can Treat OUD

    June 1, 2022

    Does your state allow it? The ongoing opioid epidemic  The U.S. hit a grim milestone of more than 100,000 drug overdose deaths,1 most opioid-involved, in the 12 months ending April 2021. This...

1 2 3 … 11Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences